JEAN-LOUIS CONSTANZA

WANDERCRAFT

Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.

dont miss

Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.

EVEN MORE SEMINARS

  • Prof Jenny Freeman: Speaking at the European Neurological Convention

    Prof Jenny Freeman
    University of Plymouth

    Physiotherapy research in MS: An overview and reflections on the clinical implications?

  • Prof Sara Demain: Speaking at the European Neurological Convention

    Prof Sara Demain
    University of Plymouth

    CPD Café

  • Philippe AUVRAY: Speaking at the European Neurological Convention

    Philippe AUVRAY
    NEURALLYS

    Ambulatory Intracranial pressure monitoring: a revolution for shunted patients and neurosurgeons

  • Dr Michael J. Grey: Speaking at the European Neurological Convention

    Dr Michael J. Grey
    University of East Anglia

    Effecting neuroplasticity with virtual rehabilitation

  • Mark Timmins: Speaking at the European Neurological Convention

    Mark Timmins
    St James’s Place Wealth Management

    Pension annual and lifetime allowance; what you need to know.